Abstract
Benign nodular disease of the thyroid gland is exceedingly common in most of the world. In fact, some estimates have suggested that up to 70% of the population in the United States will have thyroid nodules detectable by ultrasound. The diagnostic categories for benign nodular thyroids include both multinodular disease and dominant single nodules, which can be of neoplastic or nonneoplastic origin. The benign nodular thyroid diseases are discussed in this chapter, along with the relevant molecular pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL. Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol. 1995;4:113–121.
Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol. 2006;125 Suppl:S135-S144.
Bignell GR, Canzian F, Shayeghi M, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet. 1997;61:1123–1130.
Brix TH, Hegedus L. Genetic and environmental factors in the aetiology of simple goitre. Ann Med. 2000;32:153–156.
Castro P, Eknaes M, Teixeira MR, et al. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes. J Pathol. 2005;206:305–311.
Denning KM, Smyth PC, Cahill SF, et al. A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples. Mod Pathol. 2007;20:1095–1102.
Derrien C, Sonnet E, Gicquel I, et al. Non-hyperfunctioning nodules from multinodular goiters: a minor role in pathogenesis for somatic activating mutations in the TSH-receptor and Gsalpha subunit genes. J Endocrinol Invest. 2001;24:321–325.
Derwahl M. Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas. Exp Clin Endocrinol Diabetes. 1996;104(Suppl 4):32–35.
Djemli A, Van Vliet G, Delvin EE. Congenital hypothyroidism: from paracelsus to molecular diagnosis. Clin Biochem. 2006;39:511–518.
Drut R. Aspiration cytology of papillary hyperplastic thyroid nodule. Arch Pathol Lab Med. 2002;126:1156. author reply 1156–1157.
Ezzat S, Zheng L, Kolenda J, Safarian A, Freeman JL, Asa SL. Prevalence of activating ras mutations in morphologically characterized thyroid nodules. Thyroid. 1996;6:409–416.
Gabriel EM, Bergert ER, Grant CS, van Heerden JA, Thompson GB, Morris JC. Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter. J Clin Endocrinol Metab. 1999;84:3328–3335.
Gozu H, Avsar M, Bircan R, et al. Mutations in the thyrotropin receptor signal transduction pathway in the hyperfunctioning thyroid nodules from multinodular goiters: a study in the Turkish population. Endocr J. 2005;52:577–585.
Gruters A, Krude H, Biebermann H. Molecular genetic defects in congenital hypothyroidism. Eur J Endocrinol. 2004;151(Suppl 3):U39-U44.
Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab. 1997;82:4229–4233.
Hunt JL, Livolsi VA, Baloch ZW, et al. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol. 2003;34:375–380.
Hunt JL, Yim JH, Carty SE. Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors. Thyroid. 2006;16:643–649.
Iliszko M, Kuzniacka A, Lachinski A, Babinska M, Kobierska-Gulida G, Limon J. Karyotypic characterization of 64 nonmalignant thyroid goiters. Cancer Genet Cytogenet. 2005;161:178–180.
Karga H, Lee JK, Vickery AL Jr, Thor A, Gaz RD, Jameson JL. Ras oncogene mutations in benign and malignant thyroid neoplasms. J Clin Endocrinol Metab. 1991;73:832–836.
Khurana KK, Baloch ZW, LiVolsi VA. Aspiration cytology of pediatric solitary papillary hyperplastic thyroid nodule. Arch Pathol Lab Med. 2001;125:1575–1578.
Kratzsch J, Pulzer F. Thyroid gland development and defects. Best Pract Res Clin Endocrinol Metab. 2008;22:57–75.
Krohn K, Paschke R. Somatic mutations in thyroid nodular disease. Mol Genet Metab. 2002;75:202–208.
Lemoine NR, Mayall ES, Wyllie FS, et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. 1989;4:159–164.
Lofrano-Porto A, Barra GB, Nascimento PP, et al. Pendred syndrome in a large consanguineous Brazilian family caused by a homozygous mutation in the SLC26A4 gene. Arq Bras Endocrinol Metabol. 2008;52:1296–1303.
Mai KT, Landry DC, Thomas J, et al. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma. Histopathology. 2001;39:25–32.
Mazzaferri EL. Solitary thyroid nodule. 1. Clinical characteristics. Postgrad Med. 1981;70:98–103.
Namba H, Gutman RA, Matsuo K, Alvarez A, Fagin JA. H-ras protooncogene mutations in human thyroid neoplasms. J Clin Endocrinol Metab. 1990;71:223–229.
Namba H, Matsuo K, Fagin JA. Clonal composition of benign and malignant human thyroid tumors. J Clin Invest. 1990;86:120–125.
Namba H, Rubin SA, Fagin JA. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol Endocrinol. 1990;4:1474–1479.
Neumann S, Willgerodt H, Ackermann F, et al. Linkage of familial euthyroid goiter to the multinodular goiter-1 locus and exclusion of the candidate genes thyroglobulin, thyroperoxidase, and Na+/I- symporter. J Clin Endocrinol Metab. 1999;84:3750–3756.
Olson SE, Starling J, Chen H. Symptomatic benign multinodular goiter: unilateral or bilateral thyroidectomy? Surgery. 2007;142:458-461. discussion 461–462.
Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol. 2008;159:623–631.
Park SM, Chatterjee VK. Genetics of congenital hypothyroidism. J Med Genet. 2005;42:379–389.
Paschke R. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes. 1996;104:129–132.
Polak M. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene. Arch Med Res. 1999;30:510–513.
Rodrigues-Serpa A, Catarino A, Soares J. Loss of heterozygosity in follicular and papillary thyroid carcinomas. Cancer Genet Cytogenet. 2003;141:26–31.
Roque L, Rodrigues R, Pinto A, Moura-Nunes V, Soares J. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromosomes Cancer. 2003;36:292–302.
Sarquis MS, Weber F, Shen L, et al. High frequency of loss of heterozygosity in imprinted, compared with nonimprinted, genomic regions in follicular thyroid carcinomas and atypical adenomas. J Clin Endocrinol Metab. 2006;91:262–269.
Satta MA, Nanni S, Della Casa S, Pontecorvi A. Molecular biology of thyroid neoplasms. Rays. 2000;25:151–161.
Sykiotis GP, Sgourou A, Papachatzopoulou A, et al. A somatic mutation in the thyrotropin receptor gene in a patient with an autonomous nodule within a multinodular goiter. Hormones (Athens). 2002;1:42–46.
Tezelman S, Borucu I, Senyurek Giles Y, Tunca F, Terzioglu T. The change in surgical practice from subtotal to near-total or total thyroidectomy in the treatment of patients with benign multinodular goiter. World J Surg. 2009;33(3):400–405.
Tonacchera M, Chiovato L, Pinchera A, et al. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab. 1998;83:492–498.
Vaiman M, Nagibin A, Hagag P, Buyankin A, Olevson J, Shlamkovich N. Subtotal and near total versus total thyroidectomy for the management of multinodular goiter. World J Surg. 2008;32:1546–1551.
Weber F, Shen L, Aldred MA, et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab. 2005;90:2512–2521.
Zhao J, Leonard C, Gemsenjager E, Heitz PU, Moch H, Odermatt B. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling. Oncol Rep. 2008;19:329–337.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hunt, J.L. (2010). Benign Nodular Thyroid Disease. In: Hunt, J. (eds) Molecular Pathology of Endocrine Diseases. Molecular Pathology Library, vol 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1707-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1707-2_6
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-1706-5
Online ISBN: 978-1-4419-1707-2
eBook Packages: MedicineMedicine (R0)